Free Trial
NASDAQ:ACB

Aurora Cannabis Q2 2027 Earnings Date & Estimates

Aurora Cannabis logo
$5.08 -0.16 (-2.96%)
As of 12:13 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Aurora Cannabis is estimated to report Q2 2027 earnings on Thursday, November 5, 2026. The conference call is scheduled for 9:30 AM ET.

Upcoming Earnings Announcement

Quarter
Q2 2027
Announcement Date
Conference Call
9:30 AM ET
Upcoming Event
Earnings Conference Call
Aurora Cannabis Q2 2027
00:00 / 00:00
Live Transcript
Follow Audio

Aurora Cannabis Q2 2027 Earnings Preview

Analyst estimates for Aurora Cannabis' Q2 2027 results have not been published yet. MarketBeat will post consensus EPS and revenue estimates here as they become available. In the same quarter a year earlier Aurora Cannabis reported $0.09 per share on revenue of $64.88 million. Aurora Cannabis last reported on August 5, 2026, posting $0.04 per share and beating the -$0.13 consensus estimate. Aurora Cannabis has beaten the consensus EPS estimate in 5 of its last 8 quarters.

Recent Track Record

Last Reported
Q1 2027
Last Quarter EPS
$0.04 (Beat by +$0.17)
Last Quarter Revenue
$47.62 million
EPS Beat Rate
5 of last 8 quarters

Aurora Cannabis Q2 2027 Earnings FAQ

Aurora Cannabis (NASDAQ:ACB) is estimated to report Q2 2027 earnings on Thursday, November 5, 2026. This date is estimated from past reporting schedules and may change once the company confirms it.

Aurora Cannabis' Q2 2027 earnings conference call is scheduled for Thursday, November 5, 2026 at 9:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Aurora Cannabis' next earnings date is estimated for Thursday, November 12, 2026. MarketBeat tracks confirmed and estimated earnings dates for Aurora Cannabis on the company's earnings history page.

Aurora Cannabis Earnings Headlines

Elon Warns "America Will Go Bankrupt". Trump's Plan Inside.
The national debt just crossed $39 trillion, and Elon Musk - former head of the Department of Government Efficiency under President Trump - has gone on record saying the U.S. is '1,000% going to go bankrupt' if the trajectory doesn't change. The Trump administration preserved a little-known IRS loophole that allows everyday Americans to shield their retirement savings from the next wave of market turbulence. A free 2026 Wealth Protection Guide walks through the steps to use it.tc pixel
Organigram to buy Aurora Cannabis amid hostile bid from Curaleaf
Canadian Investment Regulatory Organization Trading Halt - ACB
See More Aurora Cannabis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aurora Cannabis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aurora Cannabis and other key companies, straight to your email.

About Aurora Cannabis

Aurora Cannabis (NASDAQ:ACB) is a Canadian cannabis company headquartered in Edmonton, Alberta. Founded in 2013, the company develops, produces, distributes and sells cannabis and cannabis-derived products for medical and adult-use markets. Its shares trade on the Toronto Stock Exchange and the Nasdaq under the symbol ACB.

Aurora’s product portfolio includes dried cannabis flower, pre-rolls, cannabis oils, softgels, vapes and other cannabis extracts. The company markets products through brands such as Aurora, San Rafael ’71, Daily Special and CanniMed, with offerings varying by market and applicable regulations.

The company serves Canada’s regulated adult-use and medical cannabis markets and has expanded its medical cannabis business internationally. Aurora has supplied medical cannabis in selected markets across Europe, Australia and South America, subject to local licensing and regulations. Miguel Martin has served as Aurora Cannabis’ chief executive officer since 2021.

View Aurora Cannabis Profile